Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort study.
Hepatol Int
; 16(5): 1170-1178, 2022 Oct.
Article
in En
| MEDLINE
| ID: mdl-36006547
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Quinolines
/
Carcinoma, Hepatocellular
/
Hypertension
/
Liver Neoplasms
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
Country/Region as subject:
Oceania
Language:
En
Journal:
Hepatol Int
Year:
2022
Type:
Article
Affiliation country:
Australia